The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis

被引:21
作者
Kim, Kisong [1 ]
Cho, Kyuyeon [1 ]
Song, Junmin [2 ]
Rahmati, Masoud [3 ]
Koyanagi, Ai [4 ,5 ]
Lee, Seung Won [6 ]
Yon, Dong Keon [7 ,8 ]
II Shin, Jae [9 ]
Smith, Lee [10 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Keimyung Univ, Sch Med, Daegu, South Korea
[3] Lorestan Univ, Fac Literature & Human Sci, Dept Phys Educ & Sport Sci, Khorramabad, Iran
[4] Univ Barcelona, Fdn St Joan de Deu, ISCIII, CIBERSAM, Parc Sanitari St Joan de Deu, St Boi De Llobregat, Barcelona, Spain
[5] ICREA, Catalan Inst Res & Adv Studies, Barcelona, Spain
[6] Sungkyunkwan Univ, Dept Precis Med, Sch Med, Suwon, South Korea
[7] Kyung Hee Univ, Med Sci Res Inst, Ctr Digital Hlth, Coll Med, Seoul, South Korea
[8] Kyung Hee Univ, Med Ctr, Dept Pediat, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Dept Pediat, Coll Med, Seoul, South Korea
[10] Anglia Ruskin Univ, Ctr Hlth Performance & Wellbeing, Dept Pediat, Cambridge, England
关键词
case fatality rate; comparison; COVID-19; delta variant; meta-analysis; Omicron Variant;
D O I
10.1002/jmv.28522
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As coronavirus variants are constantly occurring, we tried to understand more about the omicron and delta variants that have hit the world. We provided dynamic information on the case fatality rate (CFR) of the Omicron variant over time and to compare it with that of the Delta variant through meta-analysis. Twenty-four countries were selected by submission counts, submission dates, and confirmed cases. We defined the Delta or the Omicron epidemic period for individual countries as when each variant is over 90%. We further analyzed the Omicron period by dividing it into the initial plateau, increasing, and decreasing phases according to the number of newly confirmed daily cases. Finally, the meta-analysis examined the summary and between-study heterogeneity. The CFR of COVID-19 during the Omicron epidemic was lower than that during the Delta epidemic (odds ratio [OR]: 0.252, 95% confidence interval [CI] 0.205-0.309). The CFR of COVID-19 during the initial plateau phase of Omicron was higher than during other phases. (OR: 1.962, 95% CI 1.607-2.397). The CFR of COVID-19 during the increasing phase was lower than during the decreasing phases (OR: 0.412, 95% CI 0.342-0.498). The Omicron variant had lower CFR compared to the Delta variant, and the initial plateau phase had higher CFR compared to the noninitial phases. These results can help establish global health policies for COVID-19 in the future.
引用
收藏
页数:8
相关论文
共 20 条
  • [1] Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case
    Abou Ghayda, Ramy
    Lee, Keum Hwa
    Han, Young Joo
    Ryu, Seohyun
    Hong, Sung Hwi
    Yoon, Sojung
    Jeong, Gwang Hun
    Lee, Jinhee
    Lee, Jun Young
    Yang, Jae Won
    Effenberger, Maria
    Eisenhut, Michael
    Kronbichler, Andreas
    Solmi, Marco
    Lin, Han
    Jacob, Louis
    Koyanagi, Ai
    Radua, Joaquim
    Shin, Jae Il
    Smith, Lee
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 100 : 302 - 308
  • [2] Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
    Allen, Hester
    Vusirikala, Amoolya
    Flannagan, Joe
    Twohig, Katherine A.
    Zaidi, Asad
    Chudasama, Dimple
    Lamagni, Theresa
    Groves, Natalie
    Turner, Charlie
    Rawlinson, Christopher
    Lopez-Bernal, Jamie
    Harris, Ross
    Charlett, Andre
    Dabrera, Gavin
    Kall, Meaghan
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2022, 12
  • [3] The benefits, costs and feasibility of a low incidence COVID-19 strategy
    Czypionka, Thomas
    Iftekhar, Emil N.
    Prainsack, Barbara
    Priesemann, Viola
    Bauer, Simon
    Valdez, Andre Calero
    Cuschieri, Sarah
    Glaab, Enrico
    Grill, Eva
    Krutzinna, Jenny
    Lionis, Christos
    Machado, Helena
    Martins, Carlos
    Pavlakis, George N.
    Perc, Matjaz
    Petelos, Elena
    Pickersgill, Martyn
    Skupin, Alexander
    Schernhammer, Eva
    Szczurek, Ewa
    Tsiodras, Sotirios
    Willeit, Peter
    Wilmes, Paul
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2022, 13
  • [4] Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
    Deng, Xianding
    Garcia-Knight, Miguel A.
    Khalid, Mir M.
    Servellita, Venice
    Wang, Candace
    Morris, Mary Kate
    Sotomayor-Gonzalez, Alicia
    Glasner, Dustin R.
    Reyes, Kevin R.
    Gliwa, Amelia S.
    Reddy, Nikitha P.
    San Martin, Claudia Sanchez
    Federman, Scot
    Cheng, Jing
    Balcerek, Joanna
    Taylor, Jordan
    Streithorst, Jessica A.
    Miller, Steve
    Sreekumar, Bharath
    Chen, Pei-Yi
    Schulze-Gahmen, Ursula
    Taha, Taha Y.
    Hayashi, Jennifer M.
    Simoneau, Camille R.
    Kumar, G. Renuka
    McMahon, Sarah
    Lidsky, Peter, V
    Xiao, Yinghong
    Hemarajata, Peera
    Green, Nicole M.
    Espinosa, Alex
    Kath, Chantha
    Haw, Monica
    Bell, John
    Hacker, Jill K.
    Hanson, Carl
    Wadford, Debra A.
    Anaya, Carlos
    Ferguson, Donna
    Frankino, Phillip A.
    Shivram, Haridha
    Lareau, Liana F.
    Wyman, Stacia K.
    Ott, Melanie
    Andino, Raul
    Chiu, Charles Y.
    [J]. CELL, 2021, 184 (13) : 3426 - +
  • [5] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [6] Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19
    Faust, Jeremy Samuel
    Du, Chengan
    Liang, Chenxue
    Mayes, Katherine Dickerson
    Renton, Benjamin
    Panthagani, Kristen
    Krumholz, Harlan M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (01): : 74 - 76
  • [7] GISAID, GLOB SCI IN PRIM SOU
  • [8] Measuring inconsistency in meta-analyses
    Higgins, JPT
    Thompson, SG
    Deeks, JJ
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414): : 557 - 560
  • [9] A look into the future of the COVID-19 pandemic in Europe: an expert consultation
    Iftekhar, Emil Nafis
    Priesemann, Viola
    Balling, Rudi
    Bauer, Simon
    Beutels, Philippe
    Valdez, Andre Calero
    Cuschieri, Sarah
    Czypionka, Thomas
    Dumpis, Uga
    Glaab, Enrico
    Grill, Eva
    Hanson, Claudia
    Hotulainen, Pirta
    Klimek, Peter
    Kretzschmar, Mirjam
    Kruger, Tyll
    Krutzinna, Jenny
    Low, Nicola
    Machado, Helena
    Martins, Carlos
    McKee, Martin
    Mohr, Sebastian Bernd
    Nassehi, Armin
    Perc, Matjaz
    Petelos, Elena
    Pickersgill, Martyn
    Prainsack, Barbara
    Rocklov, Joacim
    Schernhammer, Eva
    Staines, Anthony
    Szczurek, Ewa
    Tsiodras, Sotirios
    Van Gucht, Steven
    Willeit, Peter
    [J]. LANCET REGIONAL HEALTH-EUROPE, 2021, 8
  • [10] Lipsitch M, 2020, LANCET INFECT DIS, V20, P775, DOI [10.1016/S1473-3099(20)30245-0, 10.1016/S1473-3099(20)30246-2]